Received Jan 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 2LY39 | IM / LL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 3255P | IM / RL |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | Y020468 | IM / RL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y020517 | SC / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | MF0425 | IM / LL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z011895 | SC / RL |
DEVELOPMENT OF A RASH ABOUT 2 WEEKS FROM THE DATE OF IMMUNIZATION WITH NO ASSOCIATED FEVER. TITERS SENT TO SCREEN FOR POSSIBLE CHICKEN POX WAS SIGNIFICANT FOR POSITIVE IGM AND ELEVATED IGM FOR VARICELLA ZOSTER
COUGH AND CONGESTION
NONE
ALBUTEROL, PREDNISOLONE, CETIRIZINE
NONE
1/19/2026 VARICELLA ZOSTER IGM 2.10 POSITIVE NORMAL RANGE <= 0.90 AND IGG 4.34, POSITIVE >1.00